T Cell-Derived IL-10 Determines Leishmaniasis Disease Outcome and Is Suppressed by a Dendritic Cell Based Vaccine

• Tobias Schwarz,

  Current address: Children's Hospital, University of Würzburg, Würzburg, Germany.

  Affiliation Institute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany

  ⨯
• Katharina A. Remer,

  Affiliation Institute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany

  ⨯
• Wiebke Nahrendorf,

  Affiliation Institute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany

  ⨯
• Anita Masic,

  Affiliation Institute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany

  ⨯
• Lisa Siewe,

  Current address: Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.

  Affiliation Department of Dermatology, University of Cologne, Cologne, Germany

  ⨯
• Werner Müller,

  Affiliations Department of Experimental Immunology, The Helmholtz Centre for Infection Research, Braunschweig, Germany, Bill Ford Chair of Cellular Immunology, Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom

  ⨯
• Axel Roers,

  Affiliations Department of Dermatology, University of Cologne, Cologne, Germany, Institute for Immunology, University of Dresden, Dresden, Germany

  ⨯
• Heidrun Moll

  * E-mail: heidrun.moll@uni-wuerzburg.de

  Affiliation Institute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany

  ⨯